Journal of Ophthalmology
Volume 2009 (2009), Article ID 360764, 39 pages
doi:10.1155/2009/360764
Review Article

Risk Factors for Age-Related Maculopathy

Paul P. Connell,1 Pearse A. Keane,1 Evelyn C. O'Neill,1 Rasha W. Altaie,1 Edward Loane,1 Kumari Neelam,1 John M. Nolan,2 and Stephen Beatty1,2

1Waterford Regional Hospital, Dunmore Road, Waterford, Ireland
2Macular Pigment Research Group, Waterford Institute of Technology, Waterford, Ireland

Received 11 February 2009; Accepted 8 July 2009

Academic Editor: Ian Grierson

Copyright © 2009 Paul P. Connell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Augood, J. R. Vingerling, P. T. V. M. de Jong, et al., “Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE),” Archives of Ophthalmology, vol. 124, no. 4, pp. 529–535, 2006. View at Publisher · View at Google Scholar · View at PubMed
  2. J. R. Evans, A. E. Fletcher, and R. P. L. Wormald, “Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community,” Ophthalmology, vol. 111, no. 3, pp. 513–517, 2004. View at Publisher · View at Google Scholar · View at PubMed
  3. S. Resnikoff, D. Pascolini, D. Etya'ale, et al., “Global data on visual impairment in the year 2002,” Bulletin of the World Health Organization, vol. 82, no. 11, pp. 844–851, 2004.
  4. R. Klein, T. Peto, A. Bird, and M. R. Vannewkirk, “The epidemiology of age-related macular degeneration,” American Journal of Ophthalmology, vol. 137, no. 3, pp. 486–495, 2004. View at Publisher · View at Google Scholar · View at PubMed
  5. D. S. Friedman, J. Katz, N. M. Bressler, B. Rahmani, and J. M. Tielsch, “Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey,” Ophthalmology, vol. 106, no. 6, pp. 1049–1055, 1999.
  6. S. J. Ryan, R. N. Mittl, and A. E. Maumenee, “The disciform response: an historical perspective,” Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie, vol. 215, no. 1, pp. 1–20, 1980.
  7. M. Chamberlain, P. Baird, M. Dirani, and R. Guymer, “Unraveling a complex genetic disease: age-related macular degeneration,” Survey of Ophthalmology, vol. 51, no. 6, pp. 576–586, 2006. View at Publisher · View at Google Scholar · View at PubMed
  8. S. Haddad, C. A. Chen, S. L. Santangelo, and J. M. Seddon, “The genetics of age-related macular degeneration: a review of progress to date,” Survey of Ophthalmology, vol. 51, no. 4, pp. 316–363, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. C. A. McCarty, “Timely translation of ophthalmic research into clinical practice,” British Journal of Ophthalmology, vol. 90, no. 9, pp. 1073–1074, 2006. View at Publisher · View at Google Scholar · View at PubMed
  10. M. B. Gorin, “A clinician's view of the molecular genetics of age-related maculopathy,” Archives of Ophthalmology, vol. 125, no. 1, pp. 21–29, 2007. View at Publisher · View at Google Scholar · View at PubMed
  11. A. Swaroop, K. E. Branham, W. Chen, and G. Abecasis, “Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits,” Human Molecular Genetics, vol. 16, no. 2, pp. R174–R182, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. J. J. M. Assink, C. C. W. Klaver, J. J. Houwing-Duistermaat, et al., “Heterogeneity of the genetic risk in age-related macular disease: a population-based familial risk study,” Ophthalmology, vol. 112, no. 3, pp. 482–487, 2005. View at Publisher · View at Google Scholar · View at PubMed
  13. C. J. Hammond, A. R. Webster, H. Snieder, A. C. Bird, C. E. Gilbert, and T. D. Spector, “Genetic influence on early age-related maculopathy: a twin study,” Ophthalmology, vol. 109, no. 4, pp. 730–736, 2002. View at Publisher · View at Google Scholar
  14. C. C. W. Klaver, M. Kliffen, C. M. van Duijn, et al., “Genetic association of apolipoprotein E with age-related macular degeneration,” American Journal of Human Genetics, vol. 63, no. 1, pp. 200–206, 1998. View at Publisher · View at Google Scholar · View at PubMed
  15. C. C. W. Klaver, R. C. W. Wolfs, J. J. M. Assink, C. M. van Duijn, A. Hofman, and P. T. V. M. de Jong, “Genetic risk of age-related maculopathy: population-based familial aggregation study,” Archives of Ophthalmology, vol. 116, no. 12, pp. 1646–1651, 1998.
  16. J. M. Seddon, U. A. Ajani, and B. D. Mitchell, “Familial aggregation of age-related maculopathy,” American Journal of Ophthalmology, vol. 123, no. 2, pp. 199–206, 1997.
  17. B. E. K. Klein, R. Klein, K. E. Lee, E. L. Moore, and L. Danforth, “Risk of incident age-related eye diseases in people with an affected sibling: the Beaver Dam Eye Study,” American Journal of Epidemiology, vol. 154, no. 3, pp. 207–211, 2001. View at Publisher · View at Google Scholar
  18. R. Klein, B. E. K. Klein, M. D. Knudtson, S. M. Meuer, M. Swift, and R. E. Gangnon, “Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study,” Ophthalmology, vol. 114, no. 2, pp. 253–262, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. R. Klein, L. Clegg, L. S. Cooper, et al., “Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study,” Archives of Ophthalmology, vol. 117, no. 9, pp. 1203–1210, 1999.
  20. R. Klein, B. E. K. Klein, S. C. Tomany, S. M. Meuer, and G.-H. Huang, “Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 109, no. 10, pp. 1767–1779, 2002. View at Publisher · View at Google Scholar
  21. R. Klein, B. E. K. Klein, S. C. Jensen, and K. J. Cruichshanks, “The relationship of ocular factors to the incidence and progression of age-related maculopathy,” Archives of Ophthalmology, vol. 116, no. 4, pp. 506–513, 1998.
  22. R. Klein, B. E. K. Klein, S. C. Jensen, and S. M. Meuer, “The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 104, no. 1, pp. 7–21, 1997.
  23. S. C. Tomany, J. J. Wang, R. Van Leeuwen, et al., “Risk factors for incident age-related macular degeneration: pooled findings from 3 continents,” Ophthalmology, vol. 111, no. 7, pp. 1280–1287, 2004. View at Publisher · View at Google Scholar · View at PubMed
  24. P. Mitchell, W. Smith, K. Attebo, and J. J. Wang, “Prevalence of age-related maculopathy in Australia: the blue mountains eye study,” Ophthalmology, vol. 102, no. 10, pp. 1450–1460, 1995.
  25. P. Mitchell, J. J. Wang, S. Foran, and W. Smith, “Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study,” Ophthalmology, vol. 109, no. 6, pp. 1092–1097, 2002. View at Publisher · View at Google Scholar
  26. W. Smith, J. Assink, R. Klein, et al., “Risk factors for age-related macular degeneration: pooled findings from three continents,” Ophthalmology, vol. 108, no. 4, pp. 697–704, 2001. View at Publisher · View at Google Scholar
  27. C. C. W. Klaver, J. J. M. Assink, R. van Leeuwen, et al., “Incidence and progression rates of age-related maculopathy: the Rotterdam Study,” Investigative Ophthalmology & Visual Science, vol. 42, no. 10, pp. 2237–2241, 2001.
  28. R. van Leeuwen, C. C. W. Klaver, J. R. Vingerling, A. Hofman, and P. T. V. M. de Jong, “The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study,” Archives of Ophthalmology, vol. 121, no. 4, pp. 519–526, 2003. View at Publisher · View at Google Scholar · View at PubMed
  29. C. Delcourt, J.-P. Cristol, F. Tessier, C. L. Léger, B. Descomps, and L. Papoz, “Age-related macular degeneration and antioxidant status in the POLA study,” Archives of Ophthalmology, vol. 117, no. 10, pp. 1384–1390, 1999.
  30. C. Delcourt, A. Lacroux, and I. Carrière, “The three-year incidence of age-related macular degeneration: the “pathologies Oculaires Liées à l'Age” (POLA) prospective study,” American Journal of Ophthalmology, vol. 140, no. 5, pp. 924–926, 2005. View at Publisher · View at Google Scholar · View at PubMed
  31. R. Varma, S. Fraser-Bell, S. Tan, R. Klein, and S. P. Azen, “Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study,” Ophthalmology, vol. 111, no. 7, pp. 1288–1297, 2004. View at Publisher · View at Google Scholar · View at PubMed
  32. C. A. McCarty, B. N. Mukesh, C. L. Fu, P. Mitchell, J. J. Wang, and H. R. Taylor, “Risk factors for age-related maculopathy: the visual impairment project,” Archives of Ophthalmology, vol. 119, no. 10, pp. 1455–1462, 2001.
  33. B. N. Mukesh, P. N. Dimitrov, S. Leikin, et al., “Five-year incidence of age-related maculopathy: the Visual Impairment Project,” Ophthalmology, vol. 111, no. 6, pp. 1176–1182, 2004. View at Publisher · View at Google Scholar · View at PubMed
  34. A. Arnarsson, T. Sverrisson, E. Stefansson, et al., “Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study,” American Journal of Ophthalmology, vol. 142, no. 3, pp. 419–428.e1, 2006. View at Publisher · View at Google Scholar · View at PubMed
  35. F. Jonasson, A. Arnarsson, T. Peto, H. Sasaki, K. Sasaki, and A. C. Bird, “5-year incidence of age-related maculopathy in the Reykjavik Eye Study,” Ophthalmology, vol. 112, no. 1, pp. 132–138, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. F. Jonasson, A. Arnarsson, H. Sasaki, T. Peto, K. Sasaki, and A. C. Bird, “The prevalence of age-related maculopathy in Iceland: Reykjavik eye study,” Archives of Ophthalmology, vol. 121, no. 3, pp. 379–385, 2003.
  37. L. Xu, Y. Li, Y. Zheng, and J. B. Jonas, “Associated factors for age related maculopathy in the adult population in China: the Beijing eye study,” British Journal of Ophthalmology, vol. 90, no. 9, pp. 1087–1090, 2006. View at Publisher · View at Google Scholar · View at PubMed
  38. H. Buch, N. V. Nielsen, T. Vinding, G. B. Jensen, J. U. Prause, and M. La Cour, “14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study,” Ophthalmology, vol. 112, no. 5, pp. 787–798, 2005. View at Publisher · View at Google Scholar · View at PubMed
  39. H. Buch, T. Vinding, M. La Cour, G. B. Jensen, J. U. Prause, and N. V. Nielsen, “Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study,” Acta Ophthalmologica Scandinavica, vol. 83, no. 4, pp. 409–418, 2005. View at Publisher · View at Google Scholar · View at PubMed
  40. H. Buch, T. Vinding, M. La Cour, and N. V. Nielsen, “The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City eye study,” Acta Ophthalmologica Scandinavica, vol. 79, no. 5, pp. 441–449, 2001. View at Publisher · View at Google Scholar
  41. S. Krishnaiah, T. Das, P. K. Nirmalan, et al., “Risk factors for age-related macular degeneration: findings from the Andhra Pradesh Eye Disease Study in south India,” Investigative Ophthalmology & Visual Science, vol. 46, no. 12, pp. 4442–4449, 2005. View at Publisher · View at Google Scholar · View at PubMed
  42. L. Hyman, S.-Y. Wu, A. M. S. Connell, et al., “Prevalence and causes of visual impairment in the Barbados Eye Study,” Ophthalmology, vol. 108, no. 10, pp. 1751–1756, 2001. View at Publisher · View at Google Scholar
  43. M. C. Leske, S.-Y. Wu, A. Hennis, et al., “Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies,” Ophthalmology, vol. 113, no. 1, pp. 29–35, 2006. View at Publisher · View at Google Scholar · View at PubMed
  44. M. C. Leske, S.-Y. Wu, L. Hyman, A. Hennis, B. Nemesure, and A. P. Schachat, “Four-year incidence of macular changes in the Barbados Eye Studies,” Ophthalmology, vol. 111, no. 4, pp. 706–711, 2004. View at Publisher · View at Google Scholar · View at PubMed
  45. A. P. Schachat, L. Hyman, M. C. Leske, A. M. Connell, and S. Y. Wu, “Features of age-related macular degeneration in a black population. The Barbados Eye Study Group,” Archives of Ophthalmology, vol. 113, no. 6, pp. 728–735, 1995.
  46. N. M. Bressler, S. B. Bressler, S. K. West, S. L. Fine, and H. R. Taylor, “The grading and prevalence of macular degeneration in Chesapeake Bay watermen,” Archives of Ophthalmology, vol. 107, no. 6, pp. 847–852, 1989.
  47. B. Munoz, R. Klein, J. Rodriguez, R. Snyder, and S. K. West, “Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER,” Archives of Ophthalmology, vol. 123, no. 11, pp. 1575–1580, 2005. View at Publisher · View at Google Scholar · View at PubMed
  48. P. K. Nirmalan, J. Katz, A. L. Robin, et al., “Prevalence of vitreoretinal disorders in a rural population of southern India: the Aravind Comprehensive Eye Study,” Archives of Ophthalmology, vol. 122, no. 4, pp. 581–586, 2004. View at Publisher · View at Google Scholar · View at PubMed
  49. U. Chakravarthy, C. Augood, G. C. Bentham, et al., “Cigarette smoking and age-related macular degeneration in the EUREYE Study,” Ophthalmology, vol. 114, no. 6, pp. 1157–1163, 2007. View at Publisher · View at Google Scholar · View at PubMed
  50. M. Miyazaki, Y. Kiyohara, A. Yoshida, M. Iida, Y. Nose, and T. Ishibashi, “The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study,” Investigative Ophthalmology & Visual Science, vol. 46, no. 6, pp. 1907–1910, 2005. View at Publisher · View at Google Scholar · View at PubMed
  51. M. Miyazaki, H. Nakamura, M. Kubo, et al., “Risk factors for age related maculopathy in a Japanese population: the Hisayama study,” British Journal of Ophthalmology, vol. 87, no. 4, pp. 469–472, 2003. View at Publisher · View at Google Scholar
  52. H. A. Kahn, H. M. Leibowitz, J. P. Ganley, et al., “The Framingham Eye Study. I. Outline and major prevalence findings,” American Journal of Epidemiology, vol. 106, no. 1, pp. 17–32, 1977.
  53. H. A. Kahn, H. M. Leibowitz, and J. P. Ganley, “The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study,” American Journal of Epidemiology, vol. 106, no. 1, pp. 33–41, 1977.
  54. J. Goldberg, G. Flowerdew, E. Smith, J. A. Brody, and M. O. M. Tso, “Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey,” American Journal of Epidemiology, vol. 128, no. 4, pp. 700–710, 1988.
  55. R. A. Heuberger, A. I. Fisher, P. F. Jacques, et al., “Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey,” The American Journal of Clinical Nutrition, vol. 76, no. 4, pp. 897–902, 2002.
  56. R. A. Heuberger, J. A. Mares-Perlman, R. Klein, B. E. K. Klein, A. E. Millen, and M. Palta, “Relationship of dietary fat to age-related maculopathy in the third National Health and Nutrition Examination Survey,” Archives of Ophthalmology, vol. 119, no. 12, pp. 1833–1838, 2001.
  57. R. Klein, B. E. K. Klein, E. K. Marino, et al., “Early age-related maculopathy in the cardiovascular health study,” Ophthalmology, vol. 110, no. 1, pp. 25–33, 2003. View at Publisher · View at Google Scholar
  58. L. Robman, J. McNeil, P. Dimitrov, et al., “Methodology of the cardiovascular health and age-related maculopathy (CHARM) study,” Ophthalmic Epidemiology, vol. 11, no. 3, pp. 161–179, 2004. View at Publisher · View at Google Scholar · View at PubMed
  59. N. Cheung, D. Liao, F. M. A. Islam, R. Klein, J. W. Jie, and T. Y. Wong, “Is early age-related macular degeneration related to carotid artery stiffness? The Atherosclerosis Risk in Communities Study,” British Journal of Ophthalmology, vol. 91, no. 4, pp. 430–433, 2007. View at Publisher · View at Google Scholar · View at PubMed
  60. A. Grosso, T. H. Mosley, R. Klein, D. J. Couper, G. Tikellis, and T. Y. Wong, “Is early age-related macular degeneration associated with cerebral MRI changes? The Atherosclerosis Risk in Communities study,” American Journal of Ophthalmology, vol. 143, no. 1, pp. 157–159, 2007. View at Publisher · View at Google Scholar · View at PubMed
  61. S. M. Meyers, “A twin study on age-related macular degeneration,” Transactions of the American Ophthalmological Society, vol. 92, pp. 775–843, 1994.
  62. S. M. Meyers and A. A. Zachary, “Monozygotic twins with age-related macular degeneration,” Archives of Ophthalmology, vol. 106, no. 5, pp. 651–653, 1988.
  63. J. M. Seddon, J. Cote, W. F. Page, S. H. Aggen, and M. C. Neale, “The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences,” Archives of Ophthalmology, vol. 123, no. 3, pp. 321–327, 2005. View at Publisher · View at Google Scholar · View at PubMed
  64. A. O. Edwards, R. Ritter III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer, “Complement factor H polymorphism and age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 421–424, 2005. View at Publisher · View at Google Scholar · View at PubMed
  65. P. J. Francis, D. W. Schultz, S. Hamon, J. Ott, R. G. Weleber, and M. L. Klein, “Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration,” PLoS ONE, vol. 2, no. 11, article e1197, 2007. View at Publisher · View at Google Scholar · View at PubMed
  66. J. L. Haines, M. A. Hauser, S. Schmidt, et al., “Complement factor H variant increases the risk of age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 419–421, 2005. View at Publisher · View at Google Scholar · View at PubMed
  67. S. A. Fisher, G. R. Abecasis, B. M. Yashar, et al., “Meta-analysis of genome scans of age-related macular degeneration,” Human Molecular Genetics, vol. 14, no. 15, pp. 2257–2264, 2005. View at Publisher · View at Google Scholar · View at PubMed
  68. R. K. Shuler Jr., M. A. Hauser, J. Caldwell, et al., “Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism,” Archives of Ophthalmology, vol. 125, no. 1, pp. 63–67, 2007. View at Publisher · View at Google Scholar · View at PubMed
  69. B. Gold, J. E. Merriam, J. Zernant, et al., “Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration,” Nature Genetics, vol. 38, no. 4, pp. 458–462, 2006. View at Publisher · View at Google Scholar · View at PubMed
  70. E. A. Postel, A. Agarwal, J. Caldwell, et al., “Complement factor H increases risk for atrophic age-related macular degeneration,” Ophthalmology, vol. 113, no. 9, pp. 1504–1507, 2006. View at Publisher · View at Google Scholar · View at PubMed
  71. A. E. Hughes, N. Orr, C. Patterson, et al., “Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking,” PLoS Medicine, vol. 4, no. 12, article e355, 2007. View at Publisher · View at Google Scholar · View at PubMed
  72. W. K. Scott, S. Schmidt, M. A. Hauser, et al., “Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration,” Ophthalmology, vol. 114, no. 6, pp. 1151–1156, 2007. View at Publisher · View at Google Scholar · View at PubMed
  73. A. Dewan, M. Liu, S. Hartman, et al., “HTRA1 promoter polymorphism in wet age-related macular degeneration,” Science, vol. 314, no. 5801, pp. 989–992, 2006. View at Publisher · View at Google Scholar · View at PubMed
  74. J. Jakobsdottir, Y. P. Conley, D. E. Weeks, T. S. Mah, R. E. Ferrell, and M. B. Gorin, “Susceptibility genes for age-related maculopathy on chromosome 10q26,” American Journal of Human Genetics, vol. 77, no. 3, pp. 389–407, 2005. View at Publisher · View at Google Scholar · View at PubMed
  75. N. Leveziel, E. H. Souied, F. Richard, et al., “PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population,” Molecular Vision, vol. 13, pp. 2153–2159, 2007.
  76. A. Kanda, W. Chen, M. Othman, et al., “A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16227–16232, 2007. View at Publisher · View at Google Scholar · View at PubMed
  77. R. J. Ross, C. M. Bojanowski, J. J. Wang, et al., “The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples,” Investigative Ophthalmology & Visual Science, vol. 48, no. 3, pp. 1128–1132, 2007. View at Publisher · View at Google Scholar · View at PubMed
  78. A. Rivera, S. A. Fisher, L. G. Fritsche, et al., “Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk,” Human Molecular Genetics, vol. 14, no. 21, pp. 3227–3236, 2005. View at Publisher · View at Google Scholar · View at PubMed
  79. R. W. Mahley, “Apolipoprotein E: cholesterol transport protein with expanding role in cell biology,” Science, vol. 240, no. 4852, pp. 622–630, 1988.
  80. A. J. C. Slooter, M.-X. Tang, C. M. van Duijn, et al., “Apolipoprotein E ε4 and the risk of dementia with stroke: a population-based investigation,” Journal of the American Medical Association, vol. 277, no. 10, pp. 818–821, 1997.
  81. G. Utermann, U. Langenbeck, U. Beisiegel, and W. Weber, “Genetics of the apolipoprotein E system in man,” American Journal of Human Genetics, vol. 32, no. 3, pp. 339–347, 1980.
  82. G. Tikellis, C. Sun, M. B. Gorin, et al., “Apolipoprotein E gene and age-related maculopathy in older individuals: the Cardiovascular Health Study,” Archives of Ophthalmology, vol. 125, no. 1, pp. 68–73, 2007. View at Publisher · View at Google Scholar · View at PubMed
  83. A. O. Edwards and G. Malek, “Molecular genetics of AMD and current animal models,” Angiogenesis, vol. 10, no. 2, pp. 119–132, 2007. View at Publisher · View at Google Scholar · View at PubMed
  84. G. Malek, L. V. Johnson, B. E. Mace, et al., “Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 33, pp. 11900–11905, 2005. View at Publisher · View at Google Scholar · View at PubMed
  85. P. N. Baird, E. Guida, D. T. Chu, H. T. V. Vu, and R. H. Guymer, “The ε2 and ε4 alleles of the apolipoprotein gene are associated with age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 45, no. 5, pp. 1311–1315, 2004. View at Publisher · View at Google Scholar
  86. C. M. Bojanowski, D. Shen, E. Y. Chew, et al., “An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation,” Environmental and Molecular Mutagenesis, vol. 47, no. 8, pp. 594–602, 2006. View at Publisher · View at Google Scholar · View at PubMed
  87. J. K. Boyles, C. D. Zoellner, L. J. Anderson, et al., “A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve,” Journal of Clinical Investigation, vol. 83, no. 3, pp. 1015–1031, 1989.
  88. D. W. Schultz, M. L. Klein, A. Humpert, et al., “Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration,” Archives of Ophthalmology, vol. 121, no. 5, pp. 679–683, 2003. View at Publisher · View at Google Scholar · View at PubMed
  89. E. H. Souied, P. Benlian, P. Amouyel, et al., “The ε4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration,” American Journal of Ophthalmology, vol. 125, no. 3, pp. 353–359, 1998. View at Publisher · View at Google Scholar
  90. T. Y. Wong, A. Shankar, R. Klein, et al., “Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study,” Ophthalmology, vol. 113, no. 2, pp. 255–259, 2006. View at Publisher · View at Google Scholar · View at PubMed
  91. D. L. Gordon, R. M. Kaufman, T. K. Blackmore, J. Kwong, and D. M. Lublin, “Identification of complement regulatory domains in human factor H,” The Journal of Immunology, vol. 155, no. 1, pp. 348–356, 1995.
  92. K. L. Spencer, L. M. Olson, B. M. Anderson, et al., “C3 R102G polymorphism increases risk of age-related macular degeneration,” Human Molecular Genetics, vol. 17, no. 12, pp. 1821–1824, 2008. View at Publisher · View at Google Scholar · View at PubMed
  93. Y. P. Conley, J. Jakobsdottir, T. Mah, et al., “CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses,” Human Molecular Genetics, vol. 15, no. 21, pp. 3206–3218, 2006. View at Publisher · View at Google Scholar · View at PubMed
  94. L. Badimon, “Atherosclerosis and thrombosis: lessons from animal models,” Thrombosis and Haemostasis, vol. 86, no. 1, pp. 356–365, 2001.
  95. D. G. Hackam and S. S. Anand, “Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence,” Journal of the American Medical Association, vol. 290, no. 7, pp. 932–940, 2003. View at Publisher · View at Google Scholar · View at PubMed
  96. E. Friedman, “The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration,” American Journal of Ophthalmology, vol. 130, no. 5, pp. 658–663, 2000. View at Publisher · View at Google Scholar
  97. E. Friedman, “A hemodynamic model of the pathogenesis of age-related macular degeneration,” American Journal of Ophthalmology, vol. 124, no. 5, pp. 677–682, 1997.
  98. L. Hyman, A. P. Schachat, Q. He, and M. C. Leske, “Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group,” Archives of Ophthalmology, vol. 118, no. 3, pp. 351–358, 2000.
  99. K. K. Snow and J. M. Seddon, “Age-related macular degeneration and cardiovascular disease share common antecedents?” Ophthalmic Epidemiology, vol. 6, no. 2, pp. 125–143, 1999. View at Publisher · View at Google Scholar
  100. H. S. Chung, A. Harris, T. A. Ciulla, and L. Kagemann, “Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration,” Progress in Retinal and Eye Research, vol. 18, no. 5, pp. 669–687, 1999. View at Publisher · View at Google Scholar
  101. E. Friedman, M. Ivry, E. Ebert, R. Glynn, E. Gragoudas, and J. Seddon, “Increased scleral rigidity and age-related macular degeneration,” Ophthalmology, vol. 96, no. 1, pp. 104–108, 1989.
  102. J. W. Crabb, M. Miyagi, X. Gu, et al., “Drusen proteome analysis: an approach to the etiology of age-related macular degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 23, pp. 14682–14687, 2002. View at Publisher · View at Google Scholar · View at PubMed
  103. R. F. Mullins, S. R. Russell, D. H. Anderson, and G. S. Hageman, “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease,” FASEB Journal, vol. 14, no. 7, pp. 835–846, 2000.
  104. E. Friedman, S. Krupsky, A. M. Lane, et al., “Ocular blood flow velocity in age-related macular degeneration,” Ophthalmology, vol. 102, no. 4, pp. 640–646, 1995.
  105. J. E. Grunwald, S. M. Hariprasad, J. DuPont, et al., “Foveolar choroidal blood flow in age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 39, no. 2, pp. 385–390, 1998.
  106. D. H. Anderson, R. F. Mullins, G. S. Hageman, and L. V. Johnson, “A role for local inflammation in the formation of drusen in the aging eye,” American Journal of Ophthalmology, vol. 134, no. 3, pp. 411–431, 2002. View at Publisher · View at Google Scholar
  107. V. G. Athyros, A. I. Kakafika, A. Karagiannis, and D. P. Mikhailidis, “Do we need to consider inflammatory markers when we treat atherosclerotic disease?” Atherosclerosis, vol. 200, no. 1, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at PubMed
  108. L. V. Johnson, W. P. Leitner, M. K. Staples, and D. H. Anderson, “Complement activation and inflammatory processes in drusen formation and age related macular degeneration,” Experimental Eye Research, vol. 73, no. 6, pp. 887–896, 2001. View at Publisher · View at Google Scholar · View at PubMed
  109. S. I. van Leuven, R. Franssen, J. J. Kastelein, M. Levi, E. S. G. Stroes, and P. P. Tak, “Systemic inflammation as a risk factor for atherothrombosis,” Rheumatology, vol. 47, no. 1, pp. 3–7, 2008. View at Publisher · View at Google Scholar · View at PubMed
  110. R. Klein, B. E. K. Klein, K. L. P. Linton, and D. L. DeMets, “The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking,” American Journal of Epidemiology, vol. 137, no. 2, pp. 190–200, 1993.
  111. W. Smith, P. Mitchell, and S. R. Leeder, “Smoking and age-related maculopathy: the Blue Mountains Eye Study,” Archives of Ophthalmology, vol. 114, no. 12, pp. 1518–1523, 1996.
  112. C. Delcourt, J.-L. Diaz, A. Ponton-Sanchez, and L. Papoz, “Smoking and age-related macular degeneration: the POLA study. Pathologies Oculaires Liées à l'Age,” Archives of Ophthalmology, vol. 116, no. 8, pp. 1031–1035, 1998.
  113. J. R. Vingerling, A. Hofman, D. E. Grobbee, and P. T. V. M. de Jong, “Age-related macular degeneration and smoking: the Rotterdam Study,” Archives of Ophthalmology, vol. 114, no. 10, pp. 1193–1196, 1996.
  114. S. Fraser-Bell, J. Wu, R. Klein, S. P. Azen, and R. Varma, “Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study,” American Journal of Ophthalmology, vol. 141, no. 1, pp. 79–87, 2006. View at Publisher · View at Google Scholar · View at PubMed
  115. P. Mitchell, J. J. Wang, W. Smith, and S. R. Leeder, “Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study,” Archives of Ophthalmology, vol. 120, no. 10, pp. 1357–1363, 2002.
  116. R. Klein, B. E. K. Klein, S. C. Tomany, and S. E. Moss, “Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study,” American Journal of Epidemiology, vol. 156, no. 7, pp. 589–598, 2002. View at Publisher · View at Google Scholar
  117. W. G. Christen, R. J. Glynn, J. E. Manson, U. A. Ajani, and J. E. Buring, “A prospective study of cigarette smoking and risk of age-related macular degeneration in men,” Journal of the American Medical Association, vol. 276, no. 14, pp. 1147–1151, 1996. View at Publisher · View at Google Scholar
  118. J. M. Seddon, W. C. Willett, F. E. Speizer, and S. E. Hankinson, “A prospective study of cigarette smoking and age-related macular degeneration in women,” Journal of the American Medical Association, vol. 276, no. 14, pp. 1141–1146, 1996. View at Publisher · View at Google Scholar
  119. “Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group,” Archives of Ophthalmology, vol. 110, pp. 1701–1708, 1992.
  120. A. Tamakoshi, M. Yuzawa, M. Matsui, M. Uyama, N. K. Fujiwara, and Y. Ohno, “Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. Research Committee on Chorioretinal Degenerations,” British Journal of Ophthalmology, vol. 81, no. 10, pp. 901–904, 1997.
  121. J. E. Ardourel, “Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study: age-related eye disease study report number 3,” Ophthalmology, vol. 107, no. 12, pp. 2224–2232, 2000. View at Publisher · View at Google Scholar
  122. C. Delcourt, F. Michel, A. Colvez, et al., “Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study,” Ophthalmic Epidemiology, vol. 8, no. 4, pp. 237–249, 2001. View at Publisher · View at Google Scholar
  123. J. R. Vingerling, I. Dielemans, M. L. Bots, A. Hofman, D. E. Grobbee, and P. T. V. M. de Jong, “Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study,” American Journal of Epidemiology, vol. 142, no. 4, pp. 404–409, 1995.
  124. R. van Leeuwen, M. K. Ikram, J. R. Vingerling, J. C. M. Witteman, A. Hofman, and P. T. V. M. de Jong, “Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study,” Investigative Ophthalmology & Visual Science, vol. 44, no. 9, pp. 3771–3777, 2003. View at Publisher · View at Google Scholar
  125. R. Klein, B. E. K. Klein, and S. C. Jensen, “The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 104, no. 11, pp. 1804–1812, 1997.
  126. R. Klein, B. E. K. Klein, S. C. Tomany, and K. J. Cruickshanks, “The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 110, no. 4, pp. 636–643, 2003. View at Publisher · View at Google Scholar · View at PubMed
  127. K. Marutsuka, K. Hatakeyama, A. Yamashita, and Y. Asada, “Role of thrombogenic factors in the development of atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 12, no. 1, pp. 1–8, 2005.
  128. R. Klein, B. E. K. Klein, and T. Franke, “The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 100, no. 3, pp. 406–414, 1993.
  129. R. Klein, B. E. K. Klein, M. D. Knudtson, et al., “Subclinical atherosclerotic cardiovascular disease and early age-related macular degeneration in a multiracial cohort: the Multiethnic Study of Atherosclerosis,” Archives of Ophthalmology, vol. 125, no. 4, pp. 534–543, 2007. View at Publisher · View at Google Scholar · View at PubMed
  130. R. Klein, B. E. K. Klein, and K. L. P. Linton, “Prevalence of age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 99, no. 6, pp. 933–943, 1992.
  131. Z.-J. Zheng, W. D. Rosamond, L. E. Chambless, et al., “Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: the Atherosclerosis Risk in Communities (ARIC) Study,” American Journal of Preventive Medicine, vol. 29, no. 5, supplement 1, pp. 42–49, 2005. View at Publisher · View at Google Scholar · View at PubMed
  132. F. U. S. Mattace-Raso, A. H. van den Meiracker, W. J. Bos, et al., “Arterial stiffness, cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults: the Rotterdam Study,” Journal of Hypertension, vol. 25, no. 7, pp. 1421–1426, 2007. View at Publisher · View at Google Scholar · View at PubMed
  133. N. M. van Popele, F. U. S. Mattace-Raso, R. Vliegenthart, et al., “Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults: the Rotterdam Study,” Journal of Hypertension, vol. 24, no. 12, pp. 2371–2376, 2006. View at Publisher · View at Google Scholar · View at PubMed
  134. A. I. del Sol, K. G. M. Moons, M. Hollander, et al., “Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study,” Stroke, vol. 32, no. 7, pp. 1532–1538, 2001.
  135. A. E. Odink, F. U. S. Mattace-Raso, A. van der Lugt, et al., “The association of arterial stiffness and arterial calcification: the Rotterdam Study,” Journal of Human Hypertension, vol. 22, no. 3, pp. 205–207, 2008. View at Publisher · View at Google Scholar · View at PubMed
  136. E. T. Borish, W. A. Pryor, S. Venugopal, and W. A. Deutsch, “DNA synthesis is blocked by cigarette tar-induced DNA single-strand breaks,” Carcinogenesis, vol. 8, no. 10, pp. 1517–1520, 1987.
  137. B. R. Hammond, B. R. Wooten, and D. M. Snodderly, “Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration,” Vision Research, vol. 36, no. 18, pp. 3003–3009, 1996. View at Publisher · View at Google Scholar
  138. J. Thornton, R. Edwards, P. Mitchell, R. A. Harrison, I. Buchan, and S. P. Kelly, “Smoking and age-related macular degeneration: a review of association,” Eye, vol. 19, no. 9, pp. 935–944, 2005. View at Publisher · View at Google Scholar · View at PubMed
  139. D. Bernhard and X. L. Wang, “Smoking, oxidative stress and cardiovascular diseases-do anti-oxidative therapies fail?” Current Medicinal Chemistry, vol. 14, no. 16, pp. 1703–1712, 2007. View at Publisher · View at Google Scholar
  140. S. Beatty, M. Boulton, D. Henson, H.-H. Koh, and I. J. Murray, “Macular pigment and age related macular degeneration,” British Journal of Ophthalmology, vol. 83, no. 7, pp. 867–877, 1999.
  141. R. C. Milton, T. E. Clemons, R. Klien, J. M. Seddon, and F. L. Ferris III, “Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS): AREDS report no. 19,” Ophthalmology, vol. 112, no. 4, pp. 533–539, 2005. View at Publisher · View at Google Scholar · View at PubMed
  142. J. C. Khan, D. A. Thurlby, H. Shahid, et al., “Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation,” British Journal of Ophthalmology, vol. 90, no. 1, pp. 75–80, 2006. View at Publisher · View at Google Scholar · View at PubMed
  143. T. Vinding, M. Appleyard, J. Nyboe, and G. Jensen, “Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals,” Acta Ophthalmologica, vol. 70, no. 1, pp. 66–72, 1992.
  144. M. S. Blumenkranz, S. R. Russell, and M. G. Robey, “Risk factors in age-related maculopathy complicated by choroidal neovascularization,” Ophthalmology, vol. 93, no. 5, pp. 552–558, 1986.
  145. G. Chaine, A. Hullo, J. Sahel, et al., “Case-control study of the risk factors for age related macular degeneration,” British Journal of Ophthalmology, vol. 82, no. 9, pp. 996–1002, 1998.
  146. S. K. West, F. S. Rosenthal, N. M. Bressler, et al., “Exposure to sunlight and other risk factors for age-related macular degeneration,” Archives of Ophthalmology, vol. 107, no. 6, pp. 875–879, 1989.
  147. R. Klein, B. E. K. Klein, and S. E. Moss, “Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study,” American Journal of Epidemiology, vol. 147, no. 2, pp. 103–110, 1998.
  148. A. C. Bird, N. M. Bressler, S. B. Bressler, et al., “An international classification and grading system for age-related maculopathy and age-related macular degeneration: the International ARM Epidemiological Study Group,” Survey of Ophthalmology, vol. 39, no. 5, pp. 367–374, 1995. View at Publisher · View at Google Scholar
  149. C.-J. Chiu, R. C. Milton, G. Gensler, and A. Taylor, “Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the age-related eye disease study,” The American Journal of Clinical Nutrition, vol. 86, no. 1, pp. 180–188, 2007.
  150. T. I. Metelitsina, J. E. Grunwald, J. C. DuPont, and G.-S. Ying, “Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration,” British Journal of Ophthalmology, vol. 90, no. 3, pp. 342–346, 2006. View at Publisher · View at Google Scholar · View at PubMed
  151. D. Pauleikhoff, G. Spital, M. Radermacher, G. A. Brumm, A. Lommatzsch, and A. C. Bird, “A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease,” Archives of Ophthalmology, vol. 117, no. 10, pp. 1353–1358, 1999.
  152. K. Polak, E. Polska, A. Luksch, et al., “Choroidal blood flow and arterial blood pressure,” Eye, vol. 17, no. 1, pp. 84–88, 2003. View at Publisher · View at Google Scholar · View at PubMed
  153. L. Xu, S. Wang, Y. Li, and J. B. Jonas, “Retinal vascular abnormalities and prevalence of age-related macular degeneration in adult Chinese: the Beijing Eye Study,” American Journal of Ophthalmology, vol. 142, no. 4, pp. 688–689, 2006. View at Publisher · View at Google Scholar · View at PubMed
  154. A. K. Vine, J. Stader, K. Branham, D. C. Musch, and A. Swaroop, “Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration,” Ophthalmology, vol. 112, no. 12, pp. 2076–2080, 2005. View at Publisher · View at Google Scholar · View at PubMed
  155. L. P. Santos, J. R. Diniz, A. C. Leão, and M. F. Sena, “Age-related macular degeneration: analysis in two ophthalmological centers in Pernambuco-Brazil,” Arquivos Brasileiros de Oftalmologia, vol. 68, no. 2, pp. 229–233, 2005.
  156. T. Y. Wong and P. Mitchell, “Hypertensive retinopathy,” The New England Journal of Medicine, vol. 351, no. 22, pp. 2310–2317, 2004. View at Publisher · View at Google Scholar · View at PubMed
  157. G. Liew, S. Kaushik, E. Rochtchina, A. G. Tan, P. Mitchell, and J. J. Wang, “Retinal vessel signs and 10-year incident age-related maculopathy. The Blue Mountains Eye Study,” Ophthalmology, vol. 113, no. 9, pp. 1481–1487, 2006. View at Publisher · View at Google Scholar · View at PubMed
  158. J. J. Wang, P. Mitchell, E. Rochtchina, A. G. Tan, T. Y. Wong, and R. Klein, “Retinal vessel wall signs and the 5 year incidence of age related maculopathy: the Blue Mountains Eye Study,” British Journal of Ophthalmology, vol. 88, no. 1, pp. 104–109, 2004. View at Publisher · View at Google Scholar
  159. R. Klein, B. E. K. Klein, S. C. Tomany, and T. Y. Wong, “The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam Eye Study,” American Journal of Ophthalmology, vol. 137, no. 3, pp. 435–444, 2004. View at Publisher · View at Google Scholar · View at PubMed
  160. R. Klein, M. D. Knudtson, and B. E. K. Klein, “Statin use and the five-year incidence and progression of age-related macular degeneration,” American Journal of Ophthalmology, vol. 144, no. 1, pp. 1–6, 2007. View at Publisher · View at Google Scholar · View at PubMed
  161. R. van Leeuwen, C. C. W. Klaver, J. R. Vingerling, et al., “Cholesterol and age-related macular degeneration: is there a link?” American Journal of Ophthalmology, vol. 137, no. 4, pp. 750–752, 2004. View at Publisher · View at Google Scholar · View at PubMed
  162. R. van Leeuwen, J. R. Vingerling, A. Hofman, P. T. V. M. de Jong, and B. H. Ch. Stricker, “Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement,” British Medical Journal, vol. 326, no. 7383, pp. 255–256, 2003.
  163. R. Defay, C. Delcourt, M. Ranvier, A. Lacroux, and L. Papoz, “Relationships between physical activity, obesity and diabetes mellitus in a French elderly population: the POLA study. Liées à l'Age,” International Journal of Obesity, vol. 25, no. 4, pp. 512–518, 2001. View at Publisher · View at Google Scholar
  164. S. M. Grundy, “Cholesterol and coronary heart disease. A new era,” Journal of the American Medical Association, vol. 256, no. 20, pp. 2849–2858, 1986.
  165. C. A. Curcio, C. L. Millican, T. Bailey, and H. S. Kruth, “Accumulation of cholesterol with age in human Bruch's membrane,” Investigative Ophthalmology & Visual Science, vol. 42, no. 1, pp. 265–274, 2001.
  166. S. R. Russell, R. F. Mullins, B. L. Schneider, and G. S. Hageman, “Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration,” American Journal of Ophthalmology, vol. 129, no. 2, pp. 205–214, 2000. View at Publisher · View at Google Scholar
  167. R. van Leeuwen, S. C. Tomany, J. J. Wang, et al., “Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents,” Ophthalmology, vol. 111, no. 6, pp. 1169–1175, 2004. View at Publisher · View at Google Scholar · View at PubMed
  168. R. Klein, B. E. K. Klein, S. C. Jensen, et al., “Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study,” Archives of Ophthalmology, vol. 119, no. 9, pp. 1354–1359, 2001.
  169. J. S. L. Tan, P. Mitchell, E. Rochtchina, and J. J. Wang, “Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study,” American Journal of Ophthalmology, vol. 143, no. 4, pp. 685–687, 2007. View at Publisher · View at Google Scholar · View at PubMed
  170. R. Klein, B. E. K. Klein, S. C. Tomany, L. G. Danforth, and K. J. Cruickshanks, “Relation of statin use to the 5-year incidence and progression of age-related maculopathy,” Archives of Ophthalmology, vol. 121, no. 8, pp. 1151–1155, 2003. View at Publisher · View at Google Scholar · View at PubMed
  171. J. Nolan, O. O'Donovan, H. Kavanagh, et al., “Macular pigment and percentage of body fat,” Investigative Ophthalmology & Visual Science, vol. 45, no. 11, pp. 3940–3950, 2004. View at Publisher · View at Google Scholar · View at PubMed
  172. A. Kassoff, J. Kassoff, J. Buehler, et al., “A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8,” Archives of Ophthalmology, vol. 119, no. 10, pp. 1417–1436, 2001.
  173. S. Beatty, H.-H. Koh, M. Phil, D. Henson, and M. Boulton, “The role of oxidative stress in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 45, no. 2, pp. 115–134, 2000. View at Publisher · View at Google Scholar
  174. C. R. Gale, N. F. Hall, D. I. W. Phillips, and C. N. Martyn, “Lutein and zeaxanthin status and risk of age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 44, no. 6, pp. 2461–2465, 2003. View at Publisher · View at Google Scholar
  175. J. P. SanGiovanni, E. Y. Chew, T. E. Clemons, et al., “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22,” Archives of Ophthalmology, vol. 125, no. 9, pp. 1225–1232, 2007. View at Publisher · View at Google Scholar · View at PubMed
  176. J. M. Nolan, J. Stack, E. O'Connell, and S. Beatty, “The relationships between macular pigment optical density and its constituent carotenoids in diet and serum,” Investigative Ophthalmology & Visual Science, vol. 48, no. 2, pp. 571–582, 2007. View at Publisher · View at Google Scholar · View at PubMed
  177. A. De Lorenzo, V. Del Gobbo, M. G. Premrov, M. Bigioni, F. Galvano, and L. Di Renzo, “Normal-weight obese syndrome: early inflammation?” The American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 40–45, 2007.
  178. D. A. Schaumberg, W. G. Christen, S. E. Hankinson, and R. J. Glynn, “Body mass index and the incidence of visually significant age-related maculopathy in men,” Archives of Ophthalmology, vol. 119, no. 9, pp. 1259–1265, 2001.
  179. J. M. Seddon, J. Cote, N. Davis, and B. Rosner, “Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio,” Archives of Ophthalmology, vol. 121, no. 6, pp. 785–792, 2003. View at Publisher · View at Google Scholar · View at PubMed
  180. B. E. K. Klein, R. Klein, S. C. Jensen, L. L. Ritter, and T. C. Burton, “Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study,” Transactions of the American Ophthalmological Society, vol. 92, pp. 289–297, 1994.
  181. B. E. K. Klein, R. Klein, and K. E. Lee, “Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study,” American Journal of Ophthalmology, vol. 130, no. 3, pp. 322–326, 2000. View at Publisher · View at Google Scholar
  182. J. J. Wang, B. Taylor, T. Y. Wong, et al., “Retinal vessel diameters and obesity: a population-based study in older persons,” Obesity, vol. 14, no. 2, pp. 206–214, 2006. View at Publisher · View at Google Scholar · View at PubMed
  183. D. E. R. Warburton, C. W. Nicol, and S. S. D. Bredin, “Health benefits of physical activity: the evidence,” Canadian Medical Association Journal, vol. 174, no. 6, pp. 801–809, 2006. View at Publisher · View at Google Scholar · View at PubMed
  184. K. R. Wilund, “Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?” Clinical Science, vol. 112, no. 11-12, pp. 543–555, 2007. View at Publisher · View at Google Scholar · View at PubMed
  185. J. K. Smith, “Exercise and atherogenesis,” Exercise and Sport Sciences Reviews, vol. 29, no. 2, pp. 49–53, 2001.
  186. J. K. Smith, R. Dykes, J. E. Douglas, G. Krishnaswamy, and S. Berk, “Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease,” Journal of the American Medical Association, vol. 281, no. 18, pp. 1722–1727, 1999. View at Publisher · View at Google Scholar
  187. M. D. Knudtson, R. Klein, and B. E. K. Klein, “Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study,” British Journal of Ophthalmology, vol. 90, no. 12, pp. 1461–1463, 2006. View at Publisher · View at Google Scholar · View at PubMed
  188. W. Smith, P. Mitchell, and J. J. Wang, “Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study,” Australian and New Zealand Journal of Ophthalmology, vol. 25, supplement 1, pp. S13–S15, 1997.
  189. R. Defay, S. Pinchinat, S. Lumbroso, et al., “Sex steroids and age-related macular degeneration in older French women: the POLA study,” Annals of Epidemiology, vol. 14, no. 3, pp. 202–208, 2004. View at Publisher · View at Google Scholar · View at PubMed
  190. E. E. Freeman, B. Munoz, S. B. Bressler, and S. K. West, “Hormone replacement therapy, reproductive factors, and age-related macular degeneration: the Salisbury Eye Evaluation Project,” Ophthalmic Epidemiology, vol. 12, no. 1, pp. 37–45, 2005. View at Publisher · View at Google Scholar · View at PubMed
  191. P. K. Nirmalan, J. Katz, A. L. Robin, et al., “Female reproductive factors and eye disease in a rural south Indian population: the Aravind Comprehensive Eye Survey,” Investigative Ophthalmology & Visual Science, vol. 45, no. 12, pp. 4273–4276, 2004. View at Publisher · View at Google Scholar · View at PubMed
  192. J. R. Vingerling, I. Dielemans, J. C. M. Witteman, A. Hofman, D. E. Grobbee, and P. T. V. M. de Jong, “Macular degeneration and early menopause: a case-control study,” British Medical Journal, vol. 310, no. 6994, pp. 1570–1571, 1995.
  193. G. McGwin Jr., T. A. Hall, A. Xie, and C. Owsley, “The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study,” British Journal of Ophthalmology, vol. 89, no. 9, pp. 1166–1170, 2005. View at Publisher · View at Google Scholar · View at PubMed
  194. R. Klein, B. E. K. Klein, S. C. Tomany, and K. J. Cruickshanks, “Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy,” Archives of Ophthalmology, vol. 121, no. 5, pp. 674–678, 2003. View at Publisher · View at Google Scholar · View at PubMed
  195. R. Klein, B. E. K. Klein, M. D. Knudtson, T. Y. Wong, A. Shankar, and M. Y. Tsai, “Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy,” American Journal of Ophthalmology, vol. 140, no. 1, pp. 35–44, 2005. View at Publisher · View at Google Scholar · View at PubMed
  196. J. J. Wang, P. Mitchell, W. Smith, M. Gillies, and F. Billson, “Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study,” Ophthalmic Epidemiology, vol. 10, no. 1, pp. 37–48, 2003. View at Publisher · View at Google Scholar
  197. M. Gerhard and P. Ganz, “How do we explain the clinical benefits of estrogen? From bedside to bench,” Circulation, vol. 92, no. 1, pp. 5–8, 1995.
  198. G. M. C. Rosano, C. Vitale, and M. Fini, “Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?” Annals of the New York Academy of Sciences, vol. 1092, pp. 341–348, 2006. View at Publisher · View at Google Scholar · View at PubMed
  199. M. T. Subbiah, “Mechanisms of cardioprotection by estrogens,” Experimental Biology and Medicine, vol. 217, no. 1, pp. 23–29, 1998.
  200. F. Grodstein, M. J. Stampfer, J. E. Manson, et al., “Postmenopausal estrogen and progestin use and the risk of cardiovascular disease,” The New England Journal of Medicine, vol. 335, no. 7, pp. 453–461, 1996. View at Publisher · View at Google Scholar
  201. S. Hulley, D. Grady, T. Bush, et al., “Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group,” Journal of the American Medical Association, vol. 280, no. 7, pp. 605–613, 1998. View at Publisher · View at Google Scholar
  202. J. A. E. Manson, J. Hsia, K. C. Johnson, et al., “Estrogen plus progestin and the risk of coronary heart disease,” The New England Journal of Medicine, vol. 349, no. 6, pp. 523–534, 2003. View at Publisher · View at Google Scholar · View at PubMed
  203. M. S. Linet, “Invited commentary: postmenopausal unopposed estrogen and breast cancer risk in the Women's Health Initiative—before and beyond,” American Journal of Epidemiology, vol. 167, no. 12, pp. 1416–1420, 2008.
  204. P. M. Ridker, M. J. Stampfer, and N. Rifai, “Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease,” Journal of the American Medical Association, vol. 285, no. 19, pp. 2481–2485, 2001.
  205. E. Ernst, D. E. Hammerschmidt, U. Bagge, A. Matrai, and J. A. Dormandy, “Leukocytes and the risk of ischemic diseases,” Journal of the American Medical Association, vol. 257, no. 17, pp. 2318–2324, 1987.
  206. E. Rochtchina, J. J. Wang, V. M. Flood, and P. Mitchell, “Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study,” American Journal of Ophthalmology, vol. 143, no. 2, pp. 344–346, 2007. View at Publisher · View at Google Scholar · View at PubMed
  207. O. Ishida, H. Oku, T. Ikeda, M. Nishimura, K. Kawagoe, and K. Nakamura, “Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?” British Journal of Ophthalmology, vol. 87, no. 5, pp. 523–524, 2003. View at Publisher · View at Google Scholar
  208. D. M. Miller, D. G. Espinosa-Heidmann, J. Legra, et al., “The association of prior cytomegalovirus infection with neovascular age-related macular degeneration,” American Journal of Ophthalmology, vol. 138, no. 3, pp. 323–328, 2004. View at Publisher · View at Google Scholar · View at PubMed
  209. L. Robman, O. Mahdi, C. McCarty, et al., “Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration,” American Journal of Epidemiology, vol. 161, no. 11, pp. 1013–1019, 2005. View at Publisher · View at Google Scholar · View at PubMed
  210. M. V. Kalayoglu, C. Galvan, O. S. Mahdi, G. I. Byrne, and S. Mansour, “Serological association between Chlamydia pneumoniae infection and age-related macular degeneration,” Archives of Ophthalmology, vol. 121, no. 4, pp. 478–482, 2003. View at Publisher · View at Google Scholar · View at PubMed
  211. L. A. Donoso, D. Kim, A. Frost, A. Callahan, and G. Hageman, “The role of inflammation in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 51, no. 2, pp. 137–152, 2006. View at Publisher · View at Google Scholar · View at PubMed
  212. H. Akiyama, “Inflammatory response in Alzheimer's disease,” Tohoku Journal of Experimental Medicine, vol. 174, no. 3, pp. 295–303, 1994.
  213. C.-M. Li, M. E. Clark, M. F. Chimento, and C. A. Curcio, “Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression,” Investigative Ophthalmology & Visual Science, vol. 47, no. 7, pp. 3119–3128, 2006. View at Publisher · View at Google Scholar · View at PubMed
  214. P. L. Penfold, M. C. Madigan, M. C. Gillies, and J. M. Provis, “Immunological and aetiological aspects of macular degeneration,” Progress in Retinal and Eye Research, vol. 20, no. 3, pp. 385–414, 2001. View at Publisher · View at Google Scholar
  215. D. D. G. Despriet, C. C. W. Klaver, J. C. M. Witteman, et al., “Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration,” Journal of the American Medical Association, vol. 296, no. 3, pp. 301–309, 2006. View at Publisher · View at Google Scholar · View at PubMed
  216. H. Hirvela, H. Luukinen, E. Laara, and L. Laatikainen, “Risk factors of age-related maculopathy in a population 70 years of age or older,” Ophthalmology, vol. 103, no. 6, pp. 871–877, 1996.
  217. W. Smith, P. Mitchell, S. R. Leeder, and J. J. Wang, “Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study,” Archives of Ophthalmology, vol. 116, no. 5, pp. 583–587, 1998.
  218. J. M. Seddon, G. Gensler, R. C. Milton, M. L. Klein, and N. Rifai, “Association between C-reactive protein and age-related macular degeneration,” Journal of the American Medical Association, vol. 291, no. 6, pp. 704–710, 2004. View at Publisher · View at Google Scholar · View at PubMed
  219. J. M. Seddon, S. George, B. Rosner, and N. Rifai, “Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers,” Archives of Ophthalmology, vol. 123, no. 6, pp. 774–782, 2005. View at Publisher · View at Google Scholar · View at PubMed
  220. I. Kardys, M. P. M. de Maat, C. C. W. Klaver, et al., “Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study),” The American Journal of Cardiology, vol. 100, no. 4, pp. 646–648, 2007. View at Publisher · View at Google Scholar · View at PubMed
  221. I. Kardys, C. C. W. Klaver, D. D. G. Despriet, et al., “A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. 1568–1575, 2006. View at Publisher · View at Google Scholar · View at PubMed
  222. H. Sies, “Oxidative stress: from basic research to clinical application,” American Journal of Medicine, vol. 91, no. 3, pp. 31S–38S, 1991.
  223. R. Klein, B. E. K. Klein, and M. D. Knudtson, “Frailty and age-related macular degeneration: the Beaver Dam Eye Study,” American Journal of Ophthalmology, vol. 140, no. 1, pp. 129–131, 2005. View at Publisher · View at Google Scholar · View at PubMed
  224. N. G. Bazan, “The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology,” Progress in Clinical and Biological Research, vol. 312, pp. 95–112, 1989.
  225. S. A. Keys and W. F. Zimmerman, “Antioxidant activity of retinol, glutathione, and taurine in bovine photoreceptor cell membranes,” Experimental Eye Research, vol. 68, no. 6, pp. 693–702, 1999. View at Publisher · View at Google Scholar · View at PubMed
  226. J. S. L. Tan, J. J. Wang, V. Flood, E. Rochtchina, W. Smith, and P. Mitchell, “Dietary antioxidants and the long-term incidence of age-related macular degeneration. The Blue Mountains Eye Study,” Ophthalmology, vol. 115, no. 2, pp. 334–341, 2008. View at Publisher · View at Google Scholar · View at PubMed
  227. L. J. Machlin and A. Bendich, “Free radical tissue damage: protective role of antioxidant nutrients,” The FASEB Journal, vol. 1, no. 6, pp. 441–445, 1987.
  228. B. Rozanowski, J. Burke, T. Sarna, and M. Rozanowska, “The pro-oxidant effects of interactions of ascorbate with photoexcited melanin fade away with aging of the retina,” Photochemistry and Photobiology, vol. 84, no. 3, pp. 658–670, 2008. View at Publisher · View at Google Scholar · View at PubMed
  229. E. W.-T. Chong, T. Y. Wong, A. J. Kreis, J. A. Simpson, and R. H. Guymer, “Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis,” British Medical Journal, vol. 335, no. 7623, pp. 755–759, 2007. View at Publisher · View at Google Scholar · View at PubMed
  230. D. I. Thurnham, J. A. Davies, B. J. Crump, R. D. Situnayake, and M. Davis, “The use of different lipids to express serum tocopherol: lipids ratios for the measurement of vitamin E status,” Annals of Clinical Biochemistry, vol. 23, no. 5, pp. 514–520, 1986.
  231. S. West, S. Vitale, J. Hallfrisch, et al., “Are antioxidants or supplements protective for age-related macular degeneration?” Archives of Ophthalmology, vol. 112, no. 2, pp. 222–227, 1994.
  232. B. Frei, L. England, and B. N. Ames, “Ascorbate is an outstanding antioxidant in human blood plasma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 16, pp. 6377–6381, 1989.
  233. W. Smith, P. Mitchell, K. Webb, and S. R. Leeder, “Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study,” Ophthalmology, vol. 106, no. 4, pp. 761–767, 1999.
  234. J. A. Mares-Perlman, R. Klein, B. E. K. Klein, et al., “Association of zinc and antioxidant nutrients with Age-related maculopathy,” Archives of Ophthalmology, vol. 114, no. 8, pp. 991–997, 1996.
  235. R. van Leeuwen, S. Boekhoorn, J. R. Vingerling, et al., “Dietary intake of antioxidants and risk of age-related macular degeneration,” Journal of the American Medical Association, vol. 294, no. 24, pp. 3101–3107, 2005. View at Publisher · View at Google Scholar · View at PubMed
  236. C. Delcourt, J.-P. Cristol, C. L. Léger, B. Descomps, and L. Papoz, “Associations of antioxidant enzymes with cataract and age-related macular degeneration: the POLA Study. Pathologies Oculaires Liées à l'Age,” Ophthalmology, vol. 106, no. 2, pp. 215–222, 1999.
  237. G. M. VandenLangenberg, J. A. Mares-Perlman, R. Klein, B. E. K. Klein, W. E. Brady, and M. Palta, “Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study,” American Journal of Epidemiology, vol. 148, no. 2, pp. 204–214, 1998.
  238. L. Packer and S. Landvik, “Vitamin E in biological systems,” Advances in Experimental Medicine and Biology, vol. 264, pp. 93–103, 1990.
  239. R. A. Alvarez, G. I. Liou, S.-L. Fong, and C. D. B. Bridges, “Levels of α- and γ-tocopherol in human eyes: evaluation of the possible role of IRBP in intraocular α-tocopherol transport,” The American Journal of Clinical Nutrition, vol. 46, no. 3, pp. 481–487, 1987.
  240. U. Singh and S. Devaraj, “Vitamin E: inflammation and atherosclerosis,” Vitamins and Hormones, vol. 76, pp. 519–549, 2007. View at Publisher · View at Google Scholar · View at PubMed
  241. R. J. Stephens, D. S. Negi, S. M. Short, F. J. G. M. Van Kuijk, E. A. Dratz, and D. W. Thomas, “Vitamin E distribution in ocular tissues following longterm dietary depletion and supplementation as determined by microdissection and gas chromatography-mas spectrometry,” Experimental Eye Research, vol. 47, no. 2, pp. 237–245, 1988.
  242. W. Smith, P. Mitchell, and C. Rochester, “Serum beta carotene, alpha tocopherol, and age-related maculopathy: the Blue Mountains Eye Study,” American Journal of Ophthalmology, vol. 124, no. 6, pp. 838–840, 1997.
  243. J. Evans, “Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis,” Eye, vol. 22, no. 6, pp. 751–760, 2008. View at Publisher · View at Google Scholar · View at PubMed
  244. J. R. Evans and K. Henshaw, “Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD000253, 2008.
  245. J. A. Mares-Perlman, A. I. Fisher, R. Klein, et al., “Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third National Health and Nutrition Examination Survey,” American Journal of Epidemiology, vol. 153, no. 5, pp. 424–432, 2001. View at Publisher · View at Google Scholar
  246. C. Delcourt, I. Carriere, M. Delage, et al., “Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study,” Investigative Ophthalmology & Visual Science, vol. 47, no. 6, pp. 2329–2335, 2006. View at Publisher · View at Google Scholar · View at PubMed
  247. P. S. Bernstein, F. Khachik, L. S. Carvalho, G. J. Muir, D.-Y. Zhao, and N. B. Katz, “Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye,” Experimental Eye Research, vol. 72, no. 3, pp. 215–223, 2001. View at Publisher · View at Google Scholar · View at PubMed
  248. R. A. Bone, J. T. Landrum, L. Fernandez, and S. L. Tarsis, “Analysis of the macular pigment by HPLC: retinal distribution and age study,” Investigative Ophthalmology & Visual Science, vol. 29, no. 6, pp. 843–849, 1988.
  249. F. Khachik, P. S. Bernstein, and D. L. Garland, “Identification of lutein and zeaxanthin oxidation products in human and monkey retinas,” Investigative Ophthalmology & Visual Science, vol. 38, no. 9, pp. 1802–1811, 1997.
  250. B. R. Hammond Jr., E. J. Johnson, R. M. Russell, et al., “Dietary modification of human macular pigment density,” Investigative Ophthalmology & Visual Science, vol. 38, no. 9, pp. 1795–1801, 1997.
  251. A. Sujak, J. Gabrielska, W. Grudzinski, R. Borc, P. Mazurek, and W. I. Gruszecki, “Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects,” Archives of Biochemistry and Biophysics, vol. 371, no. 2, pp. 301–307, 1999. View at Publisher · View at Google Scholar · View at PubMed
  252. J. A. Mares-Perlman, W. E. Brady, R. Klein, et al., “Serum antioxidants and age-related macular degeneration in a population-based case-control study,” Archives of Ophthalmology, vol. 113, no. 12, pp. 1518–1523, 1995.
  253. W. Smith, P. Mitchell, and S. R. Leeder, “Dietary fat and fish intake and age-related maculopathy,” Archives of Ophthalmology, vol. 118, no. 3, pp. 401–404, 2000.
  254. J. A. Mares-Perlman, W. E. Brady, R. Klein, G. M. VandenLangenberg, B. E. K. Klein, and M. Palta, “Dietary fat and age-related maculopathy,” Archives of Ophthalmology, vol. 113, no. 6, pp. 743–748, 1995.
  255. B. Chua, V. Flood, E. Rochtchina, J. J. Wang, W. Smith, and P. Mitchell, “Dietary fatty acids and the 5-year incidence of age-related maculopathy,” Archives of Ophthalmology, vol. 124, no. 7, pp. 981–986, 2006. View at Publisher · View at Google Scholar · View at PubMed
  256. A. H. Lichtenstein, E. Kennedy, P. Barrier, et al., “Dietary fat consumption and health,” Nutrition Reviews, vol. 56, no. 5, pp. S3–S28, 1998.
  257. W. T. Ham Jr., J. J. Ruffolo Jr., H. A. Mueller, A. M. Clarke, and M. E. Moon, “Histologic analysis of photochemical lesions produced in rhesus retina by short-wavelength light,” Investigative Ophthalmology & Visual Science, vol. 17, no. 10, pp. 1029–1035, 1978.
  258. S. C. Tomany, K. J. Cruickshanks, R. Klein, B. E. K. Klein, and M. D. Knudtson, “Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study,” Archives of Ophthalmology, vol. 122, no. 5, pp. 750–757, 2004. View at Publisher · View at Google Scholar · View at PubMed
  259. T. J. T. P. van den Berg, J. K. IJspeert, and P. W. T. de Waard, “Dependence of intraocular straylight on pigmentation and light transmission through the ocular wall,” Vision Research, vol. 31, no. 7-8, pp. 1361–1367, 1991.
  260. K. J. Cruickshanks, R. Klein, and B. F. K. Klein, “Sunlight and age-related macular degeneration: the Beaver Dam Eye Study,” Archives of Ophthalmology, vol. 111, no. 4, pp. 514–518, 1993.
  261. K. J. Cruickshanks, R. Klein, B. E. K. Klein, and D. M. Nondahl, “Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study,” Archives of Ophthalmology, vol. 119, no. 2, pp. 246–250, 2001.
  262. C. Delcourt, I. Carriere, A. Ponton-Sanchez, S. Fourrey, A. Lacroux, and L. Papoz, “Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study,” Archives of Ophthalmology, vol. 119, no. 10, pp. 1463–1468, 2001.
  263. J. J. Wang, P. Mitchell, and W. Smith, “Refractive error and age-related maculopathy: the Blue Mountains Eye Study,” Investigative Ophthalmology & Visual Science, vol. 39, no. 11, pp. 2167–2171, 1998.
  264. M. K. Ikram, R. van Leeuwen, J. R. Vingerling, A. Hofman, and P. T. V. M. de Jong, “Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study,” Investigative Ophthalmology & Visual Science, vol. 44, no. 9, pp. 3778–3782, 2003. View at Publisher · View at Google Scholar
  265. J. J. Wang, K. B. Jakobsen, W. Smith, and P. Mitchell, “Refractive status and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study,” Clinical and Experimental Ophthalmology, vol. 32, no. 3, pp. 255–258, 2004. View at Publisher · View at Google Scholar · View at PubMed
  266. T. Y. Wong, R. Klein, B. E. K. Klein, and S. C. Tomany, “Refractive errors and 10-year incidence of age-related maculopathy,” Investigative Ophthalmology & Visual Science, vol. 43, no. 9, pp. 2869–2873, 2002.
  267. M. A. Sandberg, M. J. Tolentino, S. Miller, E. L. Berson, and A. R. Gaudio, “Hyperopia and neovascularization in age-related macular degeneration,” Ophthalmology, vol. 100, no. 7, pp. 1009–1013, 1993.
  268. T. Boker, T. Fang, and R. Steinmetz, “Refractive error and choroidal perfusion characteristics in patients with choroidal neovascularization and age-related macular degeneration,” German Journal of Ophthalmology, vol. 2, no. 1, pp. 10–13, 1993.
  269. T. Vinding, “Pigmentation of the eye and hair in relation to age-related macular degeneration. An epidemiological study of 1000 aged individuals,” Acta Ophthalmologica, vol. 68, no. 1, pp. 53–58, 1990.
  270. P. Mitchell, W. Smith, and J. J. Wang, “Iris color, skin sun sensitivity, and age-related maculopathy: the Blue Mountains Eye Study,” Ophthalmology, vol. 105, no. 8, pp. 1359–1363, 1998. View at Publisher · View at Google Scholar
  271. S. C. Tomany, R. Klein, and B. E. K. Klein, “The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 110, no. 8, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar
  272. J. J. Wang, P. Mitchell, R. G. Cumming, and R. Lim, “Cataract and age-related maculopathy: the Blue Mountains Eye Study,” Ophthalmic Epidemiology, vol. 6, no. 4, pp. 317–326, 1999.
  273. R. Klein, B. E. K. Klein, Q. Wang, and S. E. Moss, “Is age-related maculopathy associated with cataracts?” Archives of Ophthalmology, vol. 112, no. 2, pp. 191–196, 1994.
  274. R. Klein, Q. Wang, B. E. K. Klein, S. E. Moss, and S. M. Meuer, “The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity,” Investigative Ophthalmology & Visual Science, vol. 36, no. 1, pp. 182–191, 1995.
  275. B. R. Hammond Jr., K. Fuld, and D. M. Snodderly, “Iris color and macular pigment optical density,” Experimental Eye Research, vol. 62, no. 3, pp. 293–297, 1996. View at Publisher · View at Google Scholar
  276. F. G. Holz, B. Piguet, D. C. Minassian, A. C. Bird, and R. A. Weale, “Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration,” American Journal of Ophthalmology, vol. 117, no. 1, pp. 19–23, 1994.
  277. E. E. Freeman, B. Munoz, S. K. West, J. M. Tielsch, and O. D. Schein, “Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies,” American Journal of Ophthalmology, vol. 135, no. 6, pp. 849–856, 2003. View at Publisher · View at Google Scholar
  278. R. Klein, B. E. K. Klein, T. Y. Wong, S. C. Tomany, and K. J. Cruickshanks, “The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study,” Archives of Ophthalmology, vol. 120, no. 11, pp. 1551–1558, 2002.
  279. J. J. Wang, R. Klein, W. Smith, B. E. K. Klein, S. Tomany, and P. Mitchell, “Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains Eye Studies,” Ophthalmology, vol. 110, no. 10, pp. 1960–1967, 2003. View at Publisher · View at Google Scholar
  280. S. Cugati, P. Mitchell, E. Rochtchina, A. G. Tan, W. Smith, and J. J. Wang, “Cataract surgery and the 10-year incidence of age-related maculopathy. The Blue Mountains Eye Study,” Ophthalmology, vol. 113, no. 11, pp. 2020–2025, 2006. View at Publisher · View at Google Scholar · View at PubMed
  281. R. E. Braunstein and J. R. Sparrow, “A blue-blocking intraocular lens should be used in cataract surgery,” Archives of Ophthalmology, vol. 123, no. 4, pp. 547–549, 2005. View at Publisher · View at Google Scholar · View at PubMed
  282. I. Y. Liu, L. White, and A. Z. LaCroix, “The association of age-related macular degeneration and lens opacities in the aged,” American Journal of Public Health, vol. 79, no. 6, pp. 765–769, 1989.
  283. M. A. Mainster, “Intraocular lenses should block UV radiation and violet but not blue light,” Archives of Ophthalmology, vol. 123, no. 4, pp. 550–555, 2005. View at Publisher · View at Google Scholar · View at PubMed
  284. R. D. Sperduto, R. Hiller, and D. Seigel, “Lens opacities and senile maculopathy,” Archives of Ophthalmology, vol. 99, no. 6, pp. 1004–1008, 1981.
  285. L. L. Ritter, R. Klein, B. E. K. Klein, J. A. Mares-Perlman, and S.C. Jensen, “Alcohol use and age-related maculopathy in the Beaver Dam Eye Study,” American Journal of Ophthalmology, vol. 120, no. 2, pp. 190–196, 1995.
  286. W. Smith and P. Mitchell, “Alcohol intake and age-related maculopathy,” American Journal of Ophthalmology, vol. 122, no. 5, pp. 743–745, 1996.
  287. T. O. Obisesan, R. Hirsch, O. Kosoko, L. Carlson, and M. Parrott, “Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1,” Journal of the American Geriatrics Society, vol. 46, no. 1, pp. 1–7, 1998.
  288. S. E. Moss, R. Klein, B. E. K. Klein, S. C. Jensen, and S. M. Meuer, “Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study,” Ophthalmology, vol. 105, no. 5, pp. 789–794, 1998. View at Publisher · View at Google Scholar
  289. A. I. Cederbaum, “Introduction: role of lipid peroxidation and oxidative stress in alcohol toxicity,” Free Radical Biology & Medicine, vol. 7, no. 5, pp. 537–539, 1989. View at Publisher · View at Google Scholar
  290. J. M. Gaziano, J. E. Buring, J. L. Breslow, et al., “Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction,” The New England Journal of Medicine, vol. 329, no. 25, pp. 1829–1834, 1993. View at Publisher · View at Google Scholar
  291. C. G. Mason, “Ocular accumulation and toxicity of certain systemically administered drugs,” Journal of Toxicology and Environmental Health, vol. 2, no. 5, pp. 977–995, 1977.
  292. K. Lotfi and J. E. Grunwald, “The effect of caffeine on the human macular circulation,” Investigative Ophthalmology & Visual Science, vol. 32, no. 12, pp. 3028–3032, 1991.
  293. S. C. Tomany, R. Klein, and B. E. K. Klein, “The relation of coffee and caffeine to the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study,” American Journal of Ophthalmology, vol. 132, no. 2, pp. 271–273, 2001. View at Publisher · View at Google Scholar